Nanomedicine in chemoradiation

Seth M. Miller, Andrew Z. Wang

Research output: Contribution to journalArticlepeer-review

24 Scopus citations


Chemoradiotherapy, the concurrent administration of chemotherapy and radiotherapy, is a treatment paradigm in oncology. It is part of the standard of care and curative treatment of many cancers. Given its importance, one of the primary goals of cancer research has been to identify agents and/or strategies that can improve the therapeutic index of chemoradiation. Recent advances in nanomedicine have provided a unique and unprecedented opportunity for improving chemoradiotherapy. Nanoparticles possess properties that are ideally suited for delivering chemotherapy in the chemoradiation setting. The goal of this review is to examine the role of incorporating nanomedicine into chemoradiation and the potential impact of nanomedicine to chemoradiotherapy.

Original languageEnglish (US)
Pages (from-to)239-250
Number of pages12
JournalTherapeutic Delivery
Issue number2
StatePublished - Feb 2013
Externally publishedYes

ASJC Scopus subject areas

  • Pharmaceutical Science


Dive into the research topics of 'Nanomedicine in chemoradiation'. Together they form a unique fingerprint.

Cite this